Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Zelira Therapeutics Limited
  6. News
  7. Summary
    ZLD   AU000000ZLD1

ZELIRA THERAPEUTICS LIMITED

(ZLD)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zelira Therapeutics Seals Germany Distribution Deal for Cannabis Medication for Insomnia; Shares Rise 11%

09/19/2021 | 10:58pm EST


© MT Newswires 2021
All news about ZELIRA THERAPEUTICS LIMITED
11/17ZELIRA THERAPEUTICS : Notification regarding unquoted securities - ZLD
PU
11/03Zelira Therapeutics Develops Cannabinoid Distillate Tech; Enters Licensing Deal with DR..
MT
10/20ZELIRA THERAPEUTICS : Jumps 15% Following $5 Million Investment from US Family Office Fund
MT
09/22ZELIRA THERAPEUTICS : Subsidiary Launches Acne Treatment Product Line in US; Shares Soar 1..
MT
09/22Zelira Therapeutics Limited Launches RAF FIVE Acne Treatment Products
CI
09/19Zelira Therapeutics Seals Germany Distribution Deal for Cannabis Medication for Insomni..
MT
08/30Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2..
CI
07/11ZELIRA THERAPEUTICS : Institutional Review Board Approves Zelira Therapeutics' Observation..
MT
07/11Zelira Therapeutics Ltd Obtains IRB Approval for US Observational Clinical Pain Trial
CI
06/20Zelira Therapeutics Ltd. Announces Clinical Trial Results of Zelira's Zenivol Published..
CI
More news
Financials
Sales 2021 0,66  0,47  0,47 
Net income 2021 -8,55 M -6,08 M -6,08 M
Net cash 2021 4,42 M 3,15 M 3,15 M
P/E ratio 2021 -5,84x
Yield 2021 -
Capitalization 46,1 M 32,8 M 32,8 M
EV / Sales 2020 -
EV / Sales 2021 70 500 112x
Nbr of Employees -
Free-Float 72,4%
Chart ZELIRA THERAPEUTICS LIMITED
Duration : Period :
Zelira Therapeutics Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZELIRA THERAPEUTICS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Managers and Directors
Oludare Odumosu Chief Executive Officer, Director & MD
Osagie O. Imasogie Chairman
Harry Karelis Non-Executive Deputy Chairman
Lisa Gray Director
Jason William Peterson Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ZELIRA THERAPEUTICS LIMITED-60.87%33
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678